Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 19;40(3):226–241. doi: 10.1177/1091581821998945

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — SRK-181 has no effect on human platelet aggregation, activation, and binding. (A) Platelet aggregation with ADP agonist was not altered by SRK-181 as compared to vehicle control. (B) Platelet activation with ADP agonist was not affected by increasing concentration of SRK-181, compared with the vehicle control. (C) SRK-181 binding to unactivated or activated platelets was low and did not increase with higher concentrations, as compared to vehicle control. Data shown in panel (A) are the mean of 4 donors ± standard deviation, while data shown in panels (B) and (C) are replicate means from one donor ± standard deviation and are representative of 4 donors.